Entrada Therapeutics, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 129.01M210.78M
Gross Profit 129.01M210.78M
Operating items
Research & Development 66.61M99.88M125.31M
Selling, General & Administrative 30.64M32.29M38.47M
Operating Expenses 97.25M132.18M163.77M
Operating Income -97.25M-3.16M47.01M
EBIT -97.25M-3.16M47.01M
Non-operating items
Interest & Investment Income 2.63M15.22M19.47M
Other Non Operating Income 2.63M15.22M19.47M
Non Operating Income 2.63M15.22M19.47M
Net income details
EBT -94.62M12.10M66.50M
Tax Provisions 18.74M0.90M
Profit After Tax -94.62M-6.68M65.63M
Income from Continuing Operations -94.62M-6.64M65.60M
Consolidated Net Income -94.62M-6.64M65.60M
Income towards Parent Company -94.62M-6.64M65.60M
Net Income towards Common Stockholders -94.62M-6.64M65.60M
Additional items
EPS (Basic) -0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 28.31M31.21M33.08M33.37M37.42M
Shares Outstanding (Diluted Average) 31.29M33.05M39.00M
EBITDA -96.67M-4.43M65.39M
Tax Rate 1.35%